Prognostic Value of Pretreatment Albumin to Globulin Ratio in Lung Cancer: A Meta-Analysis

References

• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non‐small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clinic Proc. 2008;83(5):584–594. doi:10.4065/83.5.584
   PubMed Web of Science ®Google Scholar
• Wang Y, Li S, Hu X, Wang Y, Wu Y, Li P, Che G. The prognostic value of serum albumin-globulin ratio in early-stage non-small cell lung cancer: a retrospective study. CMAR. 2019;11:3545–3554. 24doi:10.2147/CMAR.S191288
   Web of Science ®Google Scholar
• Yildirim M, Yildiz M, Duman E, Goktas S, Kaya V. Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer. J Buon. 2013;18(3):728–732.
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9(1):69. 22doi:10.1186/1475-2891-9-69
   PubMed Web of Science ®Google Scholar
• Azab B, Kedia S, Shah N, Vonfrolio S, Lu W, Naboush A, Mohammed F, Bloom SW. The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer. Int J Colorectal Dis. 2013;28(12):1629–1636. doi:10.1007/s00384-013-1748-z
   PubMed Web of Science ®Google Scholar
• Azab BN, Bhatt VR, Vonfrolio S, Bachir R, Rubinshteyn V, Alkaied H, Habeshy A, Patel J, Picon AI, Bloom SW, et al. Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. Am J Surg. 2013;206(5):764–770. doi:10.1016/j.amjsurg.2013.03.007
   PubMed Web of Science ®Google Scholar
• Duran AO, Inanc M, Karaca H, Dogan I, Berk V, Bozkurt O, Ozaslan E, Ucar M, Eroglu C, Ozkan M, et al. Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients. Asian Pacific J Cancer Prev Apjcp. 2014;15(15):6449–6453. doi:10.7314/APJCP.2014.15.15.6449
   PubMedGoogle Scholar
• Liu J, Chen S, Geng Q, Liu X, Kong P, Zhan Y, Xu D. Prognostic value of pretreatment albumin-globulin ratio in predicting longterm mortality in gastric cancer patients who underwent D2 resection. OTT. 2017; 10:2155–2162. doi:10.2147/OTT.S99282
   Web of Science ®Google Scholar
• Yao Y, Zhao M, Yuan D, Gu X, Liu H, Song Y. Elevated pretreatment serum globulin albumin ratio predicts poor prognosis for advanced non-small cell lung cancer patients. J Thorac Dis. 2014;6(9):1261–1270. Sepdoi:10.3978/j.issn.2072-1439.2014.07.13
   PubMed Web of Science ®Google Scholar
• Park S, Park S, Lee S-H, Suh B, Ock C-Y, Keam B, Kim TM, Kim D-W, Kim YW, Heo DS, et al. Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer. CBM. 2016;16(3):425–433. doi:10.3233/CBM-160581
   Web of Science ®Google Scholar
• Zhou T, He X, Fang W, Zhan J, Hong S, Qin T, Ma Y, Sheng J, Zhou N, Zhao Y, et al. Pretreatment albumin/globulin ratio predicts the prognosis for small-cell lung cancer. Medicine (Baltimore). 2016;95(12):e3097. Mardoi:10.1097/MD.0000000000003097
   PubMed Web of Science ®Google Scholar
• Li X, Qin S, Sun X, Liu D, Zhang B, Xiao G, Ren H. Prognostic significance of albumin-globulin score in patients with operable non-small-cell lung cancer. Ann Surg Oncol. 2018;25(12):3647–3659. doi:10.1245/s10434-018-6715-z
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang B, Zhu K, Wu C, Gao L, Sun X, Liu C, Wang C. Preoperative albumin-to-globulin ratio predicts survival in patients with non-small-cell lung cancer after surgery. J Cell Physiol. 2019;234(3):2471–2479. Mardoi:10.1002/jcp.26766
   PubMed Web of Science ®Google Scholar
• Zhou T, Zhao Y, Zhao S, Yang Y, Huang Y, Hou X, Zhao H, Zhang L. Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients. J Cancer. 2019; 10(7):1685–1692. doi:10.7150/jca.29319
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(1):16. Jun 7doi:10.1186/1745-6215-8-16
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008–2012. doi:10.1001/jama.283.15.2008
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi:10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455–463. doi:10.1111/j.0006-341X.2000.00455.x
   PubMed Web of Science ®Google Scholar
• Koh YW, Lee HW. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced non small cell lung cancers receiving palliative chemotherapy. Medicine. 2017;96(19):e6848. doi:10.1097/MD.0000000000006848
   PubMed Web of Science ®Google Scholar
• Cedrés S, Torrejon D, Martínez A, Martinez P, Navarro A, Zamora E, Mulet-Margalef N, Felip E. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV nonsmall cell lung cancer. Clin Transl Oncol. 2012;14(11):864–869. doi:10.1007/s12094-012-0872-5
   PubMed Web of Science ®Google Scholar
• Gu X, Sun S, Gao XS, et al. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3430 patients. Sci Rep. 2016;6:22618. doi:10.1038/srep23893
   PubMed Web of Science ®Google Scholar
• Zhang H, Xia H, Zhang L, Zhang B, Yue D, Wang C. Clinical significance of preoperative neutrophil–lymphocyte vs platelet– lymphocyte ratio in primary operable patients with non–small cell lung cancer. Am J Surg. 2015;210(3):526–535. doi:10.1016/j.amjsurg.2015.03.022
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee HW, Go SI, et al. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer. Oncotarget. 2016;7(24):36198. doi:10.18632/oncotarget.8809
   PubMedGoogle Scholar
• Li W, Ma G, Wu Q, et al. Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis. Oncotarget. 2017;8(66):110606–110613. Aug 28doi:10.18632/oncotarget.20574
   PubMedGoogle Scholar
• Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, Sugano K, Hirakawa K. The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer. BMC Cancer. 2015;15(1):347. doi:10.1186/s12885-015-1375-x
   PubMed Web of Science ®Google Scholar
• Bo Z, Wei Y, Zhou LQ, et al. Prognostic significance of preoperative albumin-globulin ratio in patients with upper tract urothelial carcinoma. PLoS One. 2015;10(12):e0144961. doi:10.1371/journal.pone.0144961
   PubMed Web of Science ®Google Scholar
• Zhang F, Sun P, Wang Z, et al. Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma. Oncotarget. 2016;7(21):30550–30560. doi:10.18632/oncotarget.8868
   PubMedGoogle Scholar
• He J, Pan H, Liang W, Xiao D, Chen X, Guo M, He J. Prognostic effect of albumin-toglobulin ratio in patients with solid tumors: a systematic review and meta-analysis. J Cancer. 2017;8(19):4002–4010. doi:10.7150/jca.21141
   PubMed Web of Science ®Google Scholar
• Chojkier M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol. 2005;39(2):143–146.
   Web of Science ®Google Scholar
• Matsumoto I, Tanaka M, Shirakawa S, Shinzeki M, Toyama H, Asari S, Goto T, Yamashita H, Ishida J, Ajiki T, et al. Postoperative serum albumin level is a marker of incomplete adjuvant chemotherapy in patients with pancreatic ductal adenocarcinom. Ann Surg Oncol. 2015;22(7):2408–2415. doi:10.1245/s10434-014-4280-7
   PubMed Web of Science ®Google Scholar
• Arrieta O, Michel Ortega RM, Villanueva-Rodríguez G, Serna-Thomé MG, Flores-Estrada D, Diaz-Romero C, Rodríguez CM, Martínez L, Sánchez-Lara K. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer. 2010;10(1):50. doi:10.1186/1471-2407-10-50
   PubMed Web of Science ®Google Scholar
• Oner F, Savaş I, Numanoğlu N. Immunoglobulins and complement components in patients with lung cancer. Tuberk Toraks. 2004;52(1):19–23.
   PubMedGoogle Scholar
• Cohen MH, Makuch R, Johnston-Early A, Ihde DC, Bunn PA, Fossieck BE, Minna JD. Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep. 1981;65(3-4):187–195.
   PubMedGoogle Scholar